Photo from wikipedia
Dyslipidaemia is an important risk factor in the development of atherosclerotic cardiovascular disease in people with diabetes. This article discusses the lipid modifying therapies available, and the current evidence and… Click to show full abstract
Dyslipidaemia is an important risk factor in the development of atherosclerotic cardiovascular disease in people with diabetes. This article discusses the lipid modifying therapies available, and the current evidence and guidance on their use in diabetes.
Keywords:
lipid modification;
modification people;
people diabetes
Journal Title: Prescriber
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Prescriber
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!